August 13, 2026
Ph.D. candidate Ying Xu’s personal connection to cardiovascular disease is fueling her research into more precise treatments for heart failure and arrhythmia. Supported by an American Heart Association predoctoral fellowship, Xu is investigating how the AKAP12-PDE8A signaling pathway disrupts heart function and whether targeting it could help protect patients from cardiac dysfunction.